ESCMID Global 2025: IL-6 Outperforms Traditional Tests for Early Sepsis Detection
A BREAKTHROUGH study presented at ESCMID Global 2025 highlights IL-6 as a highly accurate early biomarker for sepsis in neonates, children, and pregnant women, three of the most vulnerable patient groups.